a2g - GBI is not focussed on Australian market at all. Medicare funding for HPV testing in Aus is very very limited.
Therefore, you will find that tam-pap does next to zero units (has scarcely commercialised at all) and presumably Hybrid Capture 2 does a few hundred units a month. GBI's product is already in use at third biggest path company in australia - healthscope - and my recollection is they are running it about 200 times per month.
some other time i will provide a primer on growth in hpv testing globally and the part of the market that gbi is seeking to target. right now i am too tired.
a2g - GBI is not focussed on Australian market at all. Medicare...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)